Migowski Arn, Silva Gulnar Azevedo E, Dias Maria Beatriz Kneipp, Diz Maria Del Pilar Estevez, Sant'Ana Denise Rangel, Nadanovsky Paulo
Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, Brasil.
Instituto Nacional de Cardiologia, Rio de Janeiro, Brasil.
Cad Saude Publica. 2018 Jun 21;34(6):e00074817. doi: 10.1590/0102-311X00074817.
Breast cancer is the leading cause of cancer mortality in Brazilian women. The new Brazilian guidelines for early detection of breast cancer were drafted on the basis of systematic literature reviews on the possible harms and benefits of various early detection strategies. This article aims to present the recommendations and update the summary of evidence, discussing the main controversies. Breast cancer screening recommendations (in asymptomatic women) were: (i) strong recommendation against mammogram screening in women under 50 years of age; (ii) weak recommendation for mammogram screening in women 50 to 69 years of age; (iii) weak recommendation against mammogram screening in women 70 to 74 years of age; (iv) strong recommendation against mammogram screening in women 75 years or older; (v) strong recommendation that screening in the recommended age brackets should be every two years as opposed to shorter intervals; (vi) weak recommendation against teaching breast self-examination as screening; (vii) absence of recommendation for or against screening with clinical breast examination; and (viii) strong recommendation against screening with magnetic resonance imaging, ultrasonography, thermography, or tomosynthesis alone or as a complement to mammography. The recommendations for early diagnosis of breast cancer (in women with suspicious signs or symptoms) were: (i) weak recommendation for the implementation of awareness-raising strategies for early diagnosis of breast cancer; (ii) weak recommendation for use of selected signs and symptoms in the current guidelines as the criterion for urgent referral to specialized breast diagnosis services; and (iii) weak recommendation that every breast cancer diagnostic workup after the identification of suspicious signs and symptoms in primary care should be done in the same referral center.
乳腺癌是巴西女性癌症死亡的主要原因。巴西新的乳腺癌早期检测指南是在对各种早期检测策略可能的危害和益处进行系统文献综述的基础上起草的。本文旨在介绍相关建议并更新证据总结,讨论主要争议点。乳腺癌筛查建议(针对无症状女性)如下:(i)强烈建议不针对50岁以下女性进行乳房X光检查筛查;(ii)弱建议针对50至69岁女性进行乳房X光检查筛查;(iii)弱建议不针对70至74岁女性进行乳房X光检查筛查;(iv)强烈建议不针对75岁及以上女性进行乳房X光检查筛查;(v)强烈建议在推荐年龄范围内的筛查应每两年进行一次,而非更短间隔;(vi)弱建议不将乳房自我检查作为筛查方法进行传授;(vii)对于是否采用临床乳房检查进行筛查未作建议;(viii)强烈建议不单独使用磁共振成像、超声、热成像或断层合成摄影进行筛查,或作为乳房X光检查的补充筛查方法。乳腺癌早期诊断建议(针对有可疑体征或症状的女性)如下:(i)弱建议实施提高乳腺癌早期诊断意识的策略;(ii)弱建议采用现行指南中选定的体征和症状作为紧急转诊至专业乳腺癌诊断服务机构的标准;(iii)弱建议在初级保健中发现可疑体征和症状后,每次乳腺癌诊断检查均应在同一转诊中心进行。